## Sponsor Responsibilities and GCP
1. What should happen to unused investigational agents when the study is over?
- Unused investigational agents should be shipped back to the sponsor or to an alternative that the sponsor has designated. According to ICH GCP 5.14.4, the sponsor should maintain a system for the disposition of unused investigational products and for the documentation of this disposition. The investigational agents will be shipped back to the sponsor unless the sponsor authorizes an alternative method of disposition that is in compliance with applicable regulatory requirements.

2. The sponsor of a study has several responsibilities, including:
- Designating appropriately qualified medical personnel to advise on trial related medical questions or problems.

3. Which of the following is true when a sponsor's reponsibilities are transferred to a contract research organization (CRO)?
- All transferred responsibilities need to be documented in writing

4. What is a regulatory challenge of taking on the "sponsor" role in investigator-initiated studies for a sponsor-investigator that is not the regulatory responsibility of an investigator?
- Providing study monitoring

5. According to a definition used in ICH GCP, an individual (not a corporation or agency) who both initiates and conducts, alone or with others, a clinical trial, and under whose immediate direction the investigational product is administered to, despensed to, or used by a research participant is a:
- Sponsor-investigator

## Investigator's Responsibilities and GCP
1. Which of the following statements does not appear in ICH GCP 4.2 entitled "Investigator: Adequate Resources"


2. 
